MX2013000373A - Metodos mejorados para la esterilizacion de bendamustina. - Google Patents

Metodos mejorados para la esterilizacion de bendamustina.

Info

Publication number
MX2013000373A
MX2013000373A MX2013000373A MX2013000373A MX2013000373A MX 2013000373 A MX2013000373 A MX 2013000373A MX 2013000373 A MX2013000373 A MX 2013000373A MX 2013000373 A MX2013000373 A MX 2013000373A MX 2013000373 A MX2013000373 A MX 2013000373A
Authority
MX
Mexico
Prior art keywords
bendamustine
sterilization
solid
approximately
salt form
Prior art date
Application number
MX2013000373A
Other languages
English (en)
Spanish (es)
Inventor
Piyush R Patel
Rachel Y Labell
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of MX2013000373A publication Critical patent/MX2013000373A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2013000373A 2010-07-13 2011-07-12 Metodos mejorados para la esterilizacion de bendamustina. MX2013000373A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36384710P 2010-07-13 2010-07-13
PCT/US2011/043614 WO2012009299A1 (en) 2010-07-13 2011-07-12 Improved methods for the sterilization of bendamustine

Publications (1)

Publication Number Publication Date
MX2013000373A true MX2013000373A (es) 2013-02-15

Family

ID=44510172

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000373A MX2013000373A (es) 2010-07-13 2011-07-12 Metodos mejorados para la esterilizacion de bendamustina.

Country Status (8)

Country Link
US (1) US20130144068A1 (https=)
EP (1) EP2593144A1 (https=)
JP (1) JP2013534537A (https=)
CN (1) CN103052407A (https=)
AU (1) AU2011279402A1 (https=)
CA (1) CA2804865A1 (https=)
MX (1) MX2013000373A (https=)
WO (1) WO2012009299A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107375965B (zh) * 2017-07-18 2019-02-15 江门华大生物科技有限公司 中药饮片无硫杀虫保藏方法
KR102086318B1 (ko) * 2018-03-12 2020-03-09 주식회사 코스메카코리아 감마선 조사를 통한 유연성을 가지는 고형의 경시적 색변화 하이드로겔 화장료 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422068A (en) * 1994-01-05 1995-06-06 Shalaby; Shalaby W. Radiochemical sterilization
CN2225245Y (zh) * 1995-06-20 1996-04-24 鞍山钢铁公司 快速微型固体干热消毒装置
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
CN101366954B (zh) * 2008-09-19 2013-03-20 乐普（北京）医疗器械股份有限公司 一种生物涂层医疗装置的灭菌处理方法
EP2346836B1 (en) * 2008-10-08 2018-03-07 Cephalon, Inc. Processes for the preparation of bendamustine

Also Published As

Publication number Publication date
WO2012009299A1 (en) 2012-01-19
CN103052407A (zh) 2013-04-17
JP2013534537A (ja) 2013-09-05
CA2804865A1 (en) 2012-01-19
AU2011279402A1 (en) 2013-01-31
US20130144068A1 (en) 2013-06-06
EP2593144A1 (en) 2013-05-22

Similar Documents

Publication Publication Date Title
US20140142153A1 (en) Bendamustine formulations
NO335045B1 (no) Farmasøytiske formuleringer av temozolomid, fremgangsmåter for fremstilling av disse, lyofilisert pulver av formuleringene, fremstilt artikkel inneholdende det lyofiliserte pulveret, og anvendelse av formuleringene som medikament
CA2650922C (en) Pre-mixed, ready-to-use pharmaceutical compositions
JP6182262B2 (ja) 抗がん剤を含む安定な水溶性医薬組成物
US10039780B2 (en) Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
TW200944508A (en) Novel solid forms of bendamustine hydrochloride
KR102459213B1 (ko) 카르글룸산을 함유하는 약제학적 비경구 제형
EP2958554A1 (en) Stable compositions of bendamustine
KR20150132835A (ko) 변형된 가요성 플라스틱 용기에서 즉시 사용가능한 공용매 약학 조성물
JP6248189B2 (ja) 安定な抗がん剤のアルギニン塩とそれを含む組成物
MX2013000373A (es) Metodos mejorados para la esterilizacion de bendamustina.
JP6420753B2 (ja) 製剤
JP2016528261A (ja) クロロゲン酸粉末注射剤及びその製造方法
CN101181243A (zh) 一种环磷腺苷冻干制剂及其制备方法
US6316417B1 (en) Parenteral formulations comprising carbamazepine or its derivatives
US20080139609A1 (en) Granisetron compositions
CA2867224A1 (en) Process for preparing sterile brinzolamide
CN100352438C (zh) 米力农冻干粉针剂及其制备方法
JP2007533724A (ja) 無秩序なセフォベシンナトリウム塩を安定させる方法
KR20250112743A (ko) 담배 사용 장애를 포함한 질병 및 상태의 치료를 위한 바레니클린 관련 화합물 및 방법
WO2023214433A1 (en) Stable parenteral compositions of parecoxib
ES2585151T6 (es) Proceso para la fabricación de un producto de acetato de glatiramero

Legal Events

Date Code Title Description
FA Abandonment or withdrawal